| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Ms. McCracken is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Olsen is Epidemiologist, Rollins School of Public Health, Emory University; and Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Chen is Professor and Principal Investigator, Asian American Network for Cancer Awareness Research and Training; and Associate Director, Population Research and Cancer Disparities, University of California-Davis, Cancer Center, Sacramento, CA.
Dr. Jemal is Strategic Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Strategic Director, Risk Factor Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Deapen is Professor, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
This article is available online at http://CAonline.AmCancerSoc.org
Disclosures: The collection of cancer incidence data used in this study was supported by the California Department of Health Services as part of the statewide cancer-reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology, and End Results Program (SEER Program) under contract N01-PC-35136 awarded to the Northern California Cancer Center, contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries under agreement #U55/CCR921930–02 awarded to the Public Health Institute.
Funding for M.S.C.'s role is attributable to Grant Number U01 CA114640 from the National Cancer Institute and P01 CA109091–01A, funded both by the National Cancer Institute and the National Center on Minority Health and Health Disparities.
The ideas and opinions expressed herein are those of the authors, and endorsement by the State of California, Department of Health Services, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended, nor should it be inferred.
Many studies demonstrate that cancer incidence and mortality patterns among Asian Americans are heterogeneous, but national statistics on cancer for Asian ethnic groups are not routinely available. This article summarizes data on cancer incidence, mortality, risk factors, and screening for 5 of the largest Asian American ethnic groups in California. California has the largest Asian American population of any state and makes special efforts to collect health information for ethnic minority populations. We restricted our analysis to the 4 most common cancers (prostate, breast, lung, colon/rectum) and for the 3 sites known to be more common in Asian Americans (stomach, liver, cervix). Cancer incidence and mortality were summarized for 5 Asian American ethnic groups in California in order of population size (Chinese, Filipino, Vietnamese, Korean, and Japanese). Chinese Americans had among the lowest incidence and death rate from all cancer combined; however, Chinese women had the highest lung cancer death rate. Filipinos had the highest incidence and death rate from prostate cancer and the highest death rate from female breast cancer. Vietnamese had among the highest incidence and death rates from liver, lung, and cervical cancer. Korean men and women had by far the highest incidence and mortality rates from stomach cancer. Japanese experienced the highest incidence and death rates from colorectal cancer and among the highest death rates from breast and prostate cancer. Variations in cancer risk factors were also observed and were for the most part consistent with variations in cancer incidence and mortality. Differences in cancer burden among Asian American ethnic groups should be considered in the clinical setting and in cancer control planning.
This article has been cited by other articles:
|
|
 |
|
  S. L. Gomez, T. Quach, P. L. Horn-Ross, J. T. Pham, M. Cockburn, E. T. Chang, T. H. M. Keegan, S. L. Glaser, and C. A. Clarke Hidden Breast Cancer Disparities in Asian Women: Disaggregating Incidence Rates by Ethnicity and Migrant Status Am J Public Health, April 1, 2010; 100(S1): S125 - S131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kagawa-Singer, A. Valdez Dadia, M. C. Yu, and A. Surbone Cancer, Culture, and Health Disparities: Time to Chart a New Course? CA Cancer J Clin, January 1, 2010; 60(1): 12 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. X. Truong, V. T. C. Mai, H. Tanaka, L. T. Ly, T. M. Thong, H. H. Hai, D. Van Long, K. Furumatsu, M. Yoshida, H. Kutsumi, et al. Diverse Characteristics of the cagA Gene of Helicobacter pylori Strains Collected from Patients from Southern Vietnam with Gastric Cancer and Peptic Ulcer J. Clin. Microbiol., December 1, 2009; 47(12): 4021 - 4028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tomida, T. Takeuchi, Y. Shimada, C. Arima, K. Matsuo, T. Mitsudomi, Y. Yatabe, and T. Takahashi Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis J. Clin. Oncol., June 10, 2009; 27(17): 2793 - 2799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Teas, T. G. Hurley, J. R. Hebert, A. A. Franke, D. W. Sepkovic, and M. S. Kurzer Dietary Seaweed Modifies Estrogen and Phytoestrogen Metabolism in Healthy Postmenopausal Women J. Nutr., May 1, 2009; 139(5): 939 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-R. Han, H. Lee, M. T. Kim, and K. B. Kim Tailored lay health worker intervention improves breast cancer screening outcomes in non-adherent Korean-American women Health Educ. Res., April 1, 2009; 24(2): 318 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Taylor, T. T. Nguyen, J. C. Jackson, and S. J. McPhee Cervical Cancer Control Research in Vietnamese American Communities Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2924 - 2930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hou, D. Wang, R. Zhang, and H. Wang Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action Clin. Cancer Res., September 1, 2008; 14(17): 5519 - 5530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Ward Time for Renewed Commitment to Viral Hepatitis Prevention Am J Public Health, May 1, 2008; 98(5): 779 - 781. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sankaranarayanan Commentary: Cancer incidence among Asian Indians in India and abroad Int. J. Epidemiol., February 1, 2008; 37(1): 160 - 161. [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
